For Janssen

Janssen, now known as J&J Innovative Medicine, is a pioneering company at the forefront of healthcare innovation. Specializing in a wide range of therapeutic areas, Janssen is committed to developing transformative medicines that provide value to patients, healthcare professionals, and healthcare systems. With a rich research pipeline and a focus on precision medicine, the company aims to deliver targeted, personalized care to improve patient outcomes. Janssen's core products and services span across oncology, immunology, neuroscience, cardiopulmonary, and specialty ophthalmology, with a mission to address the most challenging diseases of our time.

As a leader in the pharmaceutical industry, Janssen has established a strong global presence, collaborating in more than 150 markets worldwide. The company's dedication to innovation and data science sets it apart, allowing for the discovery and development of new therapies that advance patient care. Notable achievements include being named a Fortune World's Most Admired Company and consistently ranking as a top player in the pharmaceutical industry. Janssen's commitment to patient engagement and caregiver support underscores its focus on improving the lives of those in need.

Founded on rigorous science and inspired by patient needs, Janssen continues to push the boundaries of healthcare with a forward-looking approach. The company's strategic direction involves reimagining treatments for complex diseases, harnessing AI for accelerated innovations, and expanding treatment options to reach more patients. With a relentless pursuit of excellence and a dedication to improving global health, Janssen remains at the forefront of medical breakthroughs, shaping the future of healthcare for generations to come.